Treatment failure in tuberculosis

Panickar J. R., Hoskyns W.

Source: Eur Respir J 2007; 29: 561-564

Journal Issue: March

Disease area: Paediatric lung diseases, Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Panickar J. R., Hoskyns W.. Treatment failure in tuberculosis. Eur Respir J 2007; 29: 561-564

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Latent tuberculosis infection as a cause of tuberculosis disease Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003
Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018
Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011
Latent tuberculosis infection in a drug treatment centre Source: Eur Respir J 2002; 20: Suppl. 38, 366s Year: 2002
Diagnosis of latent tuberculosis infection Source: ERS Live 2007 Year: 2007
Latent tuberculosis infection in children in contact with pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis in children Year: 2010
MOTT as a cause of treatment failure in pulmonary tuberculosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013
Completion of treatment for latent tuberculosis infection Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009
Causes of therapeutical failure in tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003
Clinical management of tuberculosis and HIV-1 co-infection Source: Eur Respir J 2010; 36: 1460-1481 Year: 2010
Acute renal failure due to rifampicin during tuberculosis treatment Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
How should we treat latent tuberculosis infection? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population Source: Eur Respir J 2005; 26: Suppl. 49, 624s Year: 2005
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 Year: 2018